HQYNasdaqServices-Business Services, NECFiscal year ends January 31

HEALTHEQUITY, INC.

Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Aug 27, 2026

$93.07+1.04 (+1.13%)

Close on Oct 19, 2026

Market cap: $7.82B
P/E (TTM): 33.6
Dividend yield: –

HEALTHEQUITY, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-01-31	FY 2025 2025-01-31	FY 2024 2024-01-31	FY 2023 2023-01-31	FY 2022 2022-01-31	FY 2021 2021-01-31	FY 2020 2020-01-31	FY 2019 2019-01-31	FY 2018 2018-01-31	FY 2017 2017-01-31	FY 2016 2016-01-31	FY 2015 2015-01-31	FY 2014 2014-01-31	FY 2013 2013-01-31
Revenue	1,313	1,200	1,000	862	757	734	532	287	230	178	127	88	62	46
Cost of Revenue	400	423	377	370	332	318	206	106	95	72	54	40	29	22
Gross Profit	913	777	623	492	425	415	326	181	135	106	73	48	33	24
Research & Development	263	240	219	193	157	125	78	35	27	22	17	11	7.14	4.23
Selling, General & Admin	215	223	183	166	144	134	105	63	48	38	27	19	12	11
Selling & Marketing	95	91	79	69	59	50	44	29	23	18	13	11	8.60	7.80
General & Administrative	120	132	104	97	85	84	61	33	25	20	14	8.34	3.90	3.37
Operating Expenses	591	615	505	483	449	381	249	104	80	65	46	31	21	17
Operating Income	322	162	118	9.06	-24	34	77	78	54	41	26	17	12	7.09
Interest Expense	57	61	55	48	37	35	25	0.27	0.27	–	–	0	0.04	0.33
Other Non-Operating Income	-45	-46	-43	-47	-43	-30	-34	-1.85	-2.23	-1.09	-0.59	-1.11	-6.15	-0.59
Asset Impairment Charges	0	0	0	0	0	0	0	0	–	–	–	–	–	–
Gain (Loss) on Investments	–	–	0	0	1.68	0	28	-0.10	-0.60	0	0	-0.02	0	0
Pretax Income	277	116	75	-38	-67	4.14	43	76	52	40	26	16	5.37	6.50
Income Tax Expense	62	19	19	-12	-22	-4.69	3.49	1.92	4.83	14	8.94	5.60	4.14	-4.67
Net Income	215	97	56	-26	-44	8.83	40	74	47	26	17	10	1.23	11
Preferred Dividends	–	–	–	–	–	–	–	–	–	0	0	1.29	2.60	2.56
Net Income to Common	–	–	–	–	–	–	–	–	–	26	17	12	-7.13	3.99
EPS (Basic)(per share)	2.50	1.11	0.65	-0.31	-0.53	0.12	0.59	1.20	0.79	0.45	0.29	0.39	-1.26	0.81
EPS (Diluted)(per share)	2.46	1.09	0.64	-0.31	-0.53	0.12	0.58	1.17	0.77	0.44	0.28	0.21	-1.26	0.25
Shares Outstanding (Basic, Weighted)(shares)	86	87	86	84	83	74	67	62	60	59	57	31	5.65	4.92
Shares Outstanding (Diluted, Weighted)(shares)	87	89	87	84	83	76	68	63	62	60	59	52	5.65	38
EBITDA	477	325	271	170	113	150	132	96	70	54	35	23	16	10

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 71.2%
Operating margin: 25.8%
Net margin: 17.4%
Return on equity, FY2026: 10.2%

Financial strength

Current ratio: 2.99
Debt to equity: 0.47
Debt to assets: 28.5%
Cash to current liabilities: 166.5%

Valuation

P/E ratio: 33.6
Price to sales: 5.74
Price to book: 3.93
Dividend yield: –